Literature DB >> 20569071

Overexpression of IGF-IR in malignant clonal cells in bone marrow of myelodysplastic syndromes.

Qi He1, Xiao Li, Zheng Zhang, Qianqiao Zhang, Feng Xu, Lianping Yang, Ying Tao, Yizhi Liu.   

Abstract

OBJECTIVE: To explore the expression level of insulin-like growth factor-1 receptor (IGF-IR) in malignant clone cells of myelodysplastic syndromes (MDS).
METHOD: Fluorescence in situ hybridization (FISH) and immunochemistry (alkaline phosphatase antialkaline phosphatase) were used together to detect the expression of IGF-IR in the bone marrow cells of 26 MDS patients with known abnormal karyotypes. RESULT: The average IGF-IR expression level on the surface of clone cells from the 26 MDS cases was markedly elevated compared with the corresponding level in normal cells (78.2 ± 13.7% vs. 14.1 ± 14.0%, p < .0001). The percentages of malignant clone cells in all 26 MDS cases were significantly correlated with the respective percentages of IGF-IR-positive nucleated cells (r = 0.909; p < .0001). No significant difference in the IGF-IR expression level on the clone cells were observed either between high- and low-risk MDS patients or among MDS patients with different abnormal karyotypes.
CONCLUSION: IGF-IR might be taken as a marker of clone cells in MDS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20569071     DOI: 10.3109/07357907.2010.489537

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  3 in total

1.  BIIB021, an Hsp90 inhibitor, effectively kills a myelodysplastic syndrome cell line via the activation of caspases and inhibition of PI3K/Akt and NF-κB pathway proteins.

Authors:  Shengyun Lin; Jing Li; Wenjing Zhou; Wenbin Qian; Bo Wang; Zhi Chen
Journal:  Exp Ther Med       Date:  2014-03-28       Impact factor: 2.447

2.  Purification of Bone Marrow Clonal Cells from Patients with Myelodysplastic Syndrome via IGF-IR.

Authors:  Qi He; Chun-Kang Chang; Feng Xu; Qing-Xia Zhang; Wen-Hui Shi; Xiao Li
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

3.  IGF‑IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway.

Authors:  Qi He; Qingqing Zheng; Feng Xu; Wenhui Shi; Juan Guo; Zheng Zhang; Sida Zhao; Xiao Li; Chunkang Chang
Journal:  Oncol Rep       Date:  2020-06-19       Impact factor: 3.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.